Journal
NATURE REVIEWS CANCER
Volume 12, Issue 8, Pages 564-571Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3278
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA078814, P30 CA023108] Funding Source: Medline
Ask authors/readers for more resources
Many studies of chemopreventive drugs have suggested that their beneficial effects on suppression of carcinogenesis and many other chronic diseases are mediated through activation of the transcription factor NFE2-related factor 2 (NRF2). More recently, genetic analyses of human tumours have indicated that NRF2 may conversely be oncogenic and cause resistance to chemotherapy. It is therefore controversial whether the activation, or alternatively the inhibition, of NRF2 is a useful strategy for the prevention or treatment of cancer. This Opinion article aims to rationalize these conflicting perspectives by critiquing the context dependence of NRF2 functions and the experimental methods behind these conflicting data.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available